Four Insiders Into a Dermatology Small Cap, Every Timeframe Says Sell
Jayson Rieger runs Verrica and just put $125,750 into his own drug maker at $5.03, and he's not alone. Four insiders have stepped in over the past 30 days, the kind of cluster that usually means the people closest to the pipeline see something the tape doesn't. The catch is the tape is ugly right now. Every timeframe reads sell, price is pinned at $4.68 support below both the 8-day and 20-day, and RSI at 36 with MFI at 20 tells you the sellers still have control. Insiders here have hit 64% of the time at 30 days for a 16.7% average return, so the read is decent, but wait for the selling to exhaust before you follow him in.
The Filing
| Ticker | VRCA |
| Company | Verrica Pharmaceuticals Inc. |
| Insider | Jayson Rieger, CEO and President |
| Buy amount | $125,750 |
| Filing date | August 18, 2026 |
| Conviction | Interesting · 64/100 |
| Setup type | Oversold Bounce |
Ultimate members received this analysis in real time.